Atrial Fibrillation Linked to Depression

Published Online: Tuesday, January 14, 2014
Follow Pharmacy_Times:
According to a German study published in PLOS ONE, atrial fibrillation may increase the risk for depression. A large sample of adults were assessed for depression on a scale using the Patient Health Questionnaire. On average, patients with atrial fibrillation scored a point higher on the scale of depression than those without atrial fibrillation. However, these scores were not severe enough to indicate the need for treatment. The study also found that atrial fibrillation patients living without a current partnership had a more prominent history of depression and self-rated their mental health status lower than those without the condition.

To read the full article on HCPLive.com, click here.
Related Articles
The FDA’s Cardiovascular and Renal Drugs Advisory Committee has recommended the approval of edoxaban (Savaysa) for treating patients with nonvalvular atrial fibrillation, a type of arrhythmia that can potentially cause a stroke.
Pfizer’s serotonin and norepinephrine reuptake inhibitor, desvenlafaxine (Pristiq), has low potential for causing sexual dysfunction in patients with major depressive disorder.
While the etiology and pathophysiology of seasonal affective disorder are not clearly understood, there may be several underlying factors that lead to its presentation.
Used alongside antidepressants, OTC analgesics and anti-inflammatories purchased from pharmacies may effectively treat patients with depression without increasing their risk of adverse events.
Latest Issues
$auto_registration$